These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets. Baaske DM; Amann AH; Wagenknecht DM; Mooers M; Carter JE; Hoyt HJ; Stoll RG Am J Hosp Pharm; 1980 Feb; 37(2):201-5. PubMed ID: 6767400 [TBL] [Abstract][Full Text] [Related]
5. [Summary of the discussion on: Problems with the clinical application technic for parenteral infusions]. Klin Anasthesiol Intensivther; 1977; (14):190-201. PubMed ID: 412008 [No Abstract] [Full Text] [Related]
6. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)]. Ahnefeld FW; Klaus E Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081 [TBL] [Abstract][Full Text] [Related]
7. Particulate contamination in parenteral nutrition solutions: still a cause for concern? Ball PA; Bethune K; Fox J; Ledger R; Barnett M Nutrition; 2001; 17(11-12):926-9. PubMed ID: 11744342 [TBL] [Abstract][Full Text] [Related]
9. Technique for microbiological testing of in-use intravenous solutions and administration sets. Lim JC Am J Hosp Pharm; 1979 Sep; 36(9):1202-4. PubMed ID: 386787 [No Abstract] [Full Text] [Related]
10. A hazard of intravenous therapy -- cored particles. Bessette MC Can Nurse; 1977 Jun; 73(6):34-5. PubMed ID: 872074 [No Abstract] [Full Text] [Related]
11. Particles in intravenous solutions: a review. Thomas WH; Lee YK N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302 [No Abstract] [Full Text] [Related]
12. In-line final filtration--a method of minimizing contamination in intravenous therapy. Ryan PB; Rapp RP; DeLuca PP; Griffen WO; Clark JD; Cloys D Bull Parenter Drug Assoc; 1973; 27(1):1-14. PubMed ID: 4686284 [No Abstract] [Full Text] [Related]
13. Comparison of two methods for obtaining size distribution characteristics of particulate matter in large-volume parenterals. Blanchard J; Schwartz JA; Byrne DM; Marx DB J Pharm Sci; 1978 Mar; 67(3):340-4. PubMed ID: 641718 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of using Travenol sets in an IVAC 230 controller. Kaka JS; Buchanan EC Hosp Pharm; 1982 May; 17(5):270-2. PubMed ID: 10255247 [TBL] [Abstract][Full Text] [Related]
16. Particle generation from equipment used for the administration of infusion fluids. Olson OT Acta Pharm Suec; 1980; 17(4):209-14. PubMed ID: 7468239 [No Abstract] [Full Text] [Related]
17. Silting index determination--an alternative to particle counting for the control of particulate contamination in infusion fluids. Ernerot L Acta Pharm Suec; 1974 Feb; 11(1):15-24. PubMed ID: 4816412 [No Abstract] [Full Text] [Related]
18. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas PA; Kuzmission A; Ikeda K; Yasuo S Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795 [TBL] [Abstract][Full Text] [Related]
19. Delivery of plasticizer from standard intravenous-administration sets. Needham TE; Jones RD N Engl J Med; 1978 Dec; 299(26):1472-3. PubMed ID: 714141 [No Abstract] [Full Text] [Related]
20. The potential hazard of particulate contamination of cardioplegic solutions. Robinson LA; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]